Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05999006 · ClinicalTrials.gov registry record · NA

Safety and Feasibility of the ELIOS System in POAG Patients

A NA study of Glaucoma, Primary Open Angle, sponsored by Elios Vision.

Recruiting
Registry status
NA
Development phase
65
Enrollment target
5
Study locations

NCT05999006 is a NA study of Glaucoma, Primary Open Angle that is actively recruiting participants, run by Elios Vision. The registered enrollment target is 65 participants, above the 58-participant average among 5 other Glaucoma, Primary Open Angle trials with a reported enrollment target (12% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05999006, a NA study of Glaucoma, Primary Open Angle, is actively recruiting participants, sponsored by Elios Vision.

RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
5
Study locations

Study Summary

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)

Interventions

  • DEVICE ELIOS Procedure

Study Locations (5)

Arizona

  • Elios Vision Clinical Site - Glendale

Florida

  • Elios Vision Clinical Site - Largo

Illinois

  • Elios Vision Clinical Site - Rock Island

Oklahoma

  • Elios Vision Clinical Site - Oklahoma City

Wisconsin

  • Elios Vision Clinical Site - Kenosha

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2023-10-18
Est. Completion 2026-04
Phase NA

Sponsor

Elios Vision

2 total trials

What the Registry Record Tells You About NCT05999006

The ClinicalTrials.gov registry entry for NCT05999006 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 5 other Glaucoma, Primary Open Angle trials with a reported enrollment target (12% higher). The listed sponsor is Elios Vision, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma, Primary Open Angle appearing as the primary indexed condition, and to 1 intervention - of which ELIOS Procedure is the first listed.

NCT05999006 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT05999006 about?

NCT05999006 is a clinical study titled "Safety and Feasibility of the ELIOS System in POAG Patients". Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)

What is the current status of trial NCT05999006?

This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2023-10-18. Estimated completion is 2026-04.

What conditions does trial NCT05999006 study?

This clinical trial studies the following conditions: Glaucoma, Primary Open Angle.

What interventions are being tested in trial NCT05999006?

The interventions under investigation include: ELIOS Procedure (DEVICE).

Who is sponsoring clinical trial NCT05999006?

This trial is sponsored by Elios Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05999006 being conducted?

This trial has 5 study locations across Arizona, Florida, Illinois, Oklahoma, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma, Primary Open Angle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.